Igor Stojkov

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Sickle Cell Disease

Randomized Controlled Trial

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Igor Stojkov, Annette Conrads-Frank, Ursula Rochau, Marjan Arvandi, Karin A Koinig, Michael Schomaker, Moshe Mittelman, Pierre Fenaux, David T Bowen, Guillermo F Sanz, Luca Malcovati, Saskia M C Langemeijer, Ulrich Germing, Krzysztof Madry, Agnès Guerci-Bresler, Dominic Culligan, Ioannis Kotsianidis, Laurence Sanhes, Juliet Mills, Sibylle Puntscher, Daniela Schmid, Corine J van Marrewijk, Alexandra G Smith, Fabio Efficace, Theo M de Witte, Reinhard Stauder, Uwe Siebert
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS registry study. Blood advances (2023)
Fabio Efficace, Karin A Koinig, Francesco Cottone, David Bowen, Moshe Mittelman, Kathrin Sommer, Saskia Langemeijer, Dominic Culligan, Kalman Filanovsky, Michael Storck, Alexandra Smith, Corine van Marrewijk, Martin Dugas, Igor Stojkov, Uwe Siebert, Theo de Witte, Reinhard Stauder
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT project. Cancer medicine (2022)
Beate Jahn, Gaby Sroczynski, Martin Bicher, Claire Rippinger, Nikolai Mühlberger, Júlia Santamaria, Christoph Urach, Michael Schomaker, Igor Stojkov, Daniela Schmid, Guenter Weiss, Ursula Wiedermann, Monika Redlberger-Fritz, Christiane Druml, Mirjam E E Kretzschmar, Maria Paulke-Korinek, Herwig Ostermann, Caroline Czasch, Gottfried Endel, Wolfgang Bock, Nikolas Popper, Uwe Siebert
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities-An Agent-Based Modeling Evaluation. Vaccines 9 (5) (2021)